Quantcast

Latest AstraZeneca Stories

2014-04-30 23:12:14

MarketReportsOnline.com adds "Global Influenza (Flu) Vaccine Market: Trends & Opportunities (2014-19)" report to its research store. Dallas, Texas (PRWEB) April 30, 2014 The report titled “Global Influenza (Flu) Vaccine Market: Trends and Opportunities (2014-2019)” provides an insight into the market dynamics and various trends and opportunities associated with the global Influenza vaccine market. It covers the global market size and growth dynamics of the influenza...

2014-04-30 23:09:43

Awards Announced from Bio-IT World Conference & Expo in Boston Boston, Mass (PRWEB) April 30, 2014 Bio-IT World announced the winners of its tenth annual Best Practices Awards competition this morning in a plenary session at the 2014 Bio-IT World Conference & Expo in Boston. Grand prize winners were named in five life sciences categories highlighting best practices in clinical trial IT, research infrastructure, bioinformatics, cloud computing and data management from AstraZeneca...

2014-04-29 20:23:44

LONDON, April 29, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:The World Market for Orphan Drugshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/world_market_orphan_drugs_1.htmlIn recent years, there has been a substantial increase in the number of drugs available to treat rare ("orphan") diseases. This comprehensive report, The World Market for Orphan Drugs, looks at this trend and provides estimates for the market opportunity in the U.S.,...

2014-04-29 08:39:29

BASEL, Switzerland, April 29, 2014 /PRNewswire/ -- At the Annual General Meeting of Syngenta AG held on April 29, 2014, the 861 shareholders representing 48.48% of the total shares approved all the motions proposed by the Board of Directors. The shareholders approved motions including a gross dividend of CHF 10.00 per share, an increase of 5% over the previous year. For the first time, in accordance with the Ordinance against Excessive Compensation at Listed...

2014-04-29 08:37:44

- Five Joint Research Projects Underway - GAITHERSBURG, Md. and ADELPHI, Md., April 29, 2014 /PRNewswire/ -- MedImmune, the global biologics research and development arm of AstraZeneca, and the University System of Maryland announced today that the initial research collaboration between MedImmune and the University of Maryland, Baltimore (UMB) has been expanded to include the University of Maryland, College Park and the University of Maryland, Baltimore County. The collaborators have also...

2014-04-24 08:32:33

RMB 60 Million Free Grant for Construction of Dedicated Production Facility BEIJING, April 24, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading China-based vaccine manufacturer, announced today that it has received notification that a RMB 60 million free government grant has been approved by China's Ministry of Finance, National Development and Reform Commission, Ministry of Industry and Information Technology, and National Health and Family Planning Commission for...

2014-04-22 23:14:55

On April 18, the FDA announced the nationwide recall of seven lots of Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL) by Hospira due to a glass defect. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) April 22, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on safety alerts for drugs including...

2014-04-17 12:29:28

LONDON, April 17, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Brain Cancer Global Clinical Trials Review, H1, 2014http://www.reportbuyer.com/pharma_healthcare/drug_discovery/brain_cancer_global_clinical_trials_review_h1_2014.htmlBrain Cancer Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, "Brain Cancer Global Clinical Trials Review, H1, 2014" provides data on the Brain Cancer clinical trial scenario. This report...

2014-04-16 08:34:34

BEIJING, April 16, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China that focuses on the research, development, manufacturing and commercialization of vaccines, announced today that it has filed its 2013 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission for the year ended December 31, 2013 on April 16, 2014. The Annual Report on Form 20-F is now available on the Company's website under SEC...

2014-04-16 00:20:38

BASEL, Switzerland, April 16, 2014 /PRNewswire/ -- -- Strong start to European season -- Ongoing emerging market growth -- North American season delayed by weather -- On track to achieve full year sales growth target Sales in the first quarter of 2014 increased by 5 percent at constant exchange rates. The increase in reported sales was 2 percent owing to the depreciation of a number of emerging market currencies against the dollar. Integrated sales Integrated sales rose...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.